10.1038/s41375-021-01143-2
Journal article
2021-08-01T00:00:00+00:00
35
2424 - 2430
6
Adult, Aged, Aged, 80 and over, COVID-19, Disease Management, Female, Humans, Male, Middle Aged, Myeloproliferative Disorders, SARS-CoV-2, Survival Analysis, United Kingdom